Advertisement NeurogesX to raise $25 million through private placement - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

NeurogesX to raise $25 million through private placement

NeurogesX has entered into a securities purchase agreement in connection with a private placement to raise approximately $25 million in gross proceeds from the sale of 4,020,910 shares of its common stock at a purchase price of $6.18 per share.

The company has also issued five-year warrants to purchase 1,206,273 additional shares of its common stock at an exercise price of $8.034 per share. The warrants were purchased at a price per underlying share of $0.125.

Pacific Growth Equities served as the exclusive placement agent for the transaction.